25 November 2024 : Clinical Research
Efficacy and Safety of Direct Oral Anticoagulants After Mechanical Thrombectomy in Venous Thromboembolism: A Comparative Study of 55 Patients
Wei-Chieh Lee123ABCDEF*, Chon-Seng Hong2BD, Wei-Ting Chang12EF, Chia-Te Liao4F, Po-Sen Huang4B, Shen-Chung Huang4B, Chih-Hsien Lin4B, Chun-Yen Chiang4B, Zhih-Cherng Chen 4F, Jhih-Yuan Shih43DFDOI: 10.12659/MSM.946362
Med Sci Monit 2024; 30:e946362
Table 3 Clinical presentation and medication use in patients with thrombophilia.
Patient number | Patient demographics | Thrombophilia type and use of OAC | ||||||
---|---|---|---|---|---|---|---|---|
Sex | Age (years) | BMI (kg/m2) | Cr (mg/dL) | Thrombophilia | Index event | Drug | Months after OAC | |
1 | Male | 75 | 15.6 | 0.58 | Thrombin III | Right iliofemoral vein | Rivaroxaban | 11 |
2 | Female | 43 | 31.8 | 0.79 | Protein S | Left iliofemoral vein | Apixaban | 23 |
3 | Female | 39 | 28.7 | 0.66 | Protein S | Bilateral pulmonary trunk embolism | Dabigatran | 6 |
4 | Male | 23 | 27.3 | 1.05 | Protein C | Left iliofemoral vein | Rivaroxaban | 20 |
5 | Male | 74 | 26.2 | 1.32 | Thrombin III | Bilateral pulmonary trunk embolism and Right iliofemoral vein | Rivaroxaban | 18 |
6 | Female | 80 | 17.4 | 0.74 | Thrombin III | Left iliofemoral vein | Rivaroxaban | 19 |
7 | Male | 71 | 25.4 | 1.5 | Protein S | Right ilio-femoral vein | Rivaroxaban | 7 |
8 | Male | 34 | 25.6 | 0.73 | Thrombin III | Bilateral pulmonary trunk embolism | Edoxaban | 5 |
9 | Male | 61 | 30.6 | 1.3 | Thrombin III | Right iliofemoral vein | Edoxaban→ Dabigatran | 2 |
10 | Male | 48 | 18.8 | 0.84 | Protein C | Bilateral pulmonary trunk embolism | Apixaban | 3 |
11 | Female | 52 | 28.3 | 1.2 | Thrombin III | Bilateral pulmonary trunk embolism and left iliofemoral vein | Apixaban | 1 |
12 | Female | 53 | 27.3 | 0.94 | Protein S | Bilateral pulmonary trunk embolism and left iliofemoral vein | Apixaban | 13 |
13 | Female | 83 | 28.8 | 0.89 | Protein S | Bilateral iliofemoral vein | Rivaroxaban | 19 |
14 | Female | 27 | 30.2 | 0.72 | Protein S | Right iliofemoral vein | Dabigatran | 12 |
BMI – body mass index; Cr – creatinine; OAC – oral anticoagulation. |